Clinical Trial Reporting: US FDA To Step Up Listings, But Not Fines, After Petition

 
• By Brenda Sandburg

Following request by Universities Allied for Essential Medicines, FDA creates a public dashboard of pre-notices of noncompliance on registering trials and submitting results to ClinicalTrials.gov. The agency denies request to impose civil penalties on those who fail to comply, citing its discretion.

Clinical trial blue with lock
FDA agrees to make pre-notices of noncompliance with clinical trial reporting requirements public • Source: Shutterstock

More from Clinical Trials

More from R&D